Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,022.00
-45.00 (-2.18%)
At close: Jan 30, 2026
Genmab Market Cap
Genmab has a market cap or net worth of 124.55 billion as of January 30, 2026. Its market cap has increased by 24.49% in one year.
Market Cap
124.55B
Enterprise Value
103.75B
Revenue
24.48B
Ranking
n/a
PE Ratio
12.65
Stock Price
2,022.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 124.55B, an increase of 3,280.76%. That is a compound annual growth rate of 14.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 124.55B | -0.25% |
| Dec 30, 2025 | 124.86B | 31.70% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.64T |
| Coloplast | 120.80B |
| Demant | 46.95B |
| ALK-Abelló | 45.92B |
| H. Lundbeck | 40.25B |
| Zealand Pharma | 29.01B |
| Ambu A/S | 22.62B |
| GN Store Nord | 15.76B |